Abstract
Mitochondrial dysfunction is implicated in the pathogenesis of Alzheimer’s disease (AD). However, the precise mitochondrial molecular deficits in AD remain poorly understood. Mitochondrial and nuclear proteomic analysis in mature male triple transgenic AD mice (PS1M146V/APPSwe/TauP301L) by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE) coupled with MALDI-TOF-MS/MS, bio-informatics analysis and immunofluorescent staining were performed in this study. In addition to impaired spatial memory impairment and intracellular accumulation of amyloid 1–42 (Aβ1–42) in the 3xTg-AD mice, a well-accepted mouse model of the human disease, we also found significantly increased DNA oxidative damage in entorhinal cortex, hippocampal CA1, CA3 and dental gyrus (DG), as evidenced by the positive staining of 8-hydroxyguanosine, a biomarker of mild cognitive impairment early in AD. We identified significant differences in 27 hippocampal mitochondrial proteins (11 increased and 16 decreased), and 37 hippocampal nuclear proteins (12 increased and 25 decreased) in 3xTg-AD mice compared with the wild-type (WT) mice. Differentially expressed mitochondrial and nuclear proteins were mainly involved in energy metabolism (>55%), synapses, DNA damage, apoptosis and oxidative stress. Two proteins were differentially expressed in both hippocampal mitochondria and nuclei, namely electron transport chain (ETC)-related protein ATP synthase subunit d (ATP5H) was significantly decreased, and apoptosis-related dynamin-1 (DYN1), a pre-synaptic and mitochondrial division-regulated protein that was significantly increased. In sum, perturbations of hippocampus mitochondrial energy metabolism-related proteins responsible for ATP generation via oxidation phosphorylation (OXPHOS), especially nuclear-encoded OXPHOS proteins, correlated with the amyloid-associated cognitive deficits of this murine AD model. The molecular changes in respiratory chain-related proteins and DYN1 may represent novel biomarkers of AD.
Highlights
Alzheimer’s disease (AD) is a common neurodegenerative disorder characterized by an age-inappropriate decline in memory, language, thinking and judgment
Mitochondrial dysfunction mainly manifests as disordered energy metabolism, perturbations in the electron transport chain (ETC), synaptic dysfunction and neuronal apoptosis (Du and Yan, 2010; Müller et al, 2010)
Seven days after the acquisition period, the probe trial was performed to evaluate the spatial memory of 3xTg-AD mice
Summary
Alzheimer’s disease (AD) is a common neurodegenerative disorder characterized by an age-inappropriate decline in memory, language, thinking and judgment. Accumulation of tau protein can cause an abnormal distribution of mitochondria within neurons (Kopeikina et al, 2011) and buildup of Aβ and APP on mitochondrial membranes can result in structural and functional damage to these critically important organelles (Pagani and Eckert, 2011; Rosales-Corral et al, 2012; Pinho et al, 2014). Mitochondrial dysfunction and dysfunctional energy metabolism are early pathological features of these diseases (Tatsuta and Langer, 2008; Pathania et al, 2009). Mitochondrial dysfunction mainly manifests as disordered energy metabolism, perturbations in the electron transport chain (ETC), synaptic dysfunction and neuronal apoptosis (Du and Yan, 2010; Müller et al, 2010). While mitochondrial dysfunction clearly plays an important role in the pathogenesis of AD, we know little about the underlying molecular mechanisms
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.